Research Topics
Species | C Lindsay DevaneSummaryAffiliation: Medical University of South Carolina Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Differential pharmacology of newer antidepressantsC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425 0742, USA
J Clin Psychiatry 59:85-93. 1998..This review summarizes some of the major pharmacokinetic and pharmacodynamic similarities and differences among these drugs...
Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)C L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425 0742, USA
Psychopharmacol Bull 35:50-61. 2001..These data do not eliminate the need for caution when prescribing antidepressants with the potential for causing metabolic interactions, but do help allay the fear that such interactions are highly prevalent and routinely hazardous...
Clinical pharmacokinetics of sertralineC Lindsay Devane
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425 0742, USA
Clin Pharmacokinet 41:1247-66. 2002..Like other selective serotonin reuptake inhibitors, sertraline is well tolerated in therapeutic dosages and relatively safe in overdosage...
Clinical significance of drug binding, protein binding, and binding displacement drug interactionsC Lindsay Devane
Laboratory of Drug Disposition and Pharmacogenetics in the Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina in Charleston, Charleston, South Carolina, USA
Psychopharmacol Bull 36:5-21. 2002..Psychopharmacology Bulletin...
Exposing fetal drug exposureL DeVane
Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina, USA
Clin Pharmacol Ther 89:786-8. 2011..Important assumptions in reproductive medicine are that fetal exposure to any medication can present risks in pregnancy--because not all risks are known, as little exposure as possible is desirable...
Antidepressant-drug interactions are potentially but rarely clinically significantC Lindsay Devane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Neuropsychopharmacology 31:1594-604; discussion 1614-5. 2006..The conclusion is drawn that drug interactions from CYP inhibition caused by the newer antidepressants are potentially, but rarely, clinically significant...
Pharmacokinetics, drug interactions, and tolerability of valproateC Lindsay Devane
Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, 67 President Street, Suite 246 North, Charleston, SC 29425, USA
Psychopharmacol Bull 37:25-42. 2003..Valproate has an extensive record of use across the lifespan and a good record of tolerability. Some precautions are warranted in its use, but valproate is generally safe whether administered alone or in combination with other therapies...
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nauseaC Lindsay Devane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Suite 246 North, Charleston, SC 29425, USA
J Clin Psychiatry 64:14-9. 2003..Although the connection has not been proven, more stable pharmacokinetic profiles might be the cause for the low occurrence of nausea with some controlled-release newer antidepressants...
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteersC Lindsay Devane
Department of Psychiatry, Medical University of South Carolina MUSC, Charleston, SC 29425, USA
J Clin Psychopharmacol 24:4-10. 2004..These results demonstrate in vivo that, unlike nefazodone, venlafaxine, sertraline, and fluoxetine do not possess significant metabolic inductive or inhibitory effects on CYP3A4...
Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an updateC Lindsay Devane
Department of Psychiatry, Medical University of South Carolina, Charleston, SC 29425, USA
Psychopharmacol Bull 37:116-32. 2003..There is a substantial published database supporting safe and effective use of risperidone for treatment of psychosis, agitation, and aggression in elderly patients...
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay Devane
Department of Psychiatry and Behavioral Sciences, 67 President Street, Medical University of South Carolina, Charleston, SC 29425, USA
Psychopharmacol Bull 36:40-52. 2002..The newer drugs for treatment of type 2 diabetes are discussed, and considerations are given for avoiding or minimizing drug interactions when prescribing psychoactive drugs to patients with diabetes...
An evaluation of risperidone drug interactionsC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425 0742, USA
J Clin Psychopharmacol 21:408-16. 2001..Adherence to a few guidelines for the design of dosage regimens should limit the effect of drug-drug interactions on patient status and contribute to optimal pharmacotherapy with risperidone...
Pharmacologic characteristics of ideal antidepressants in the 21st centuryC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
J Clin Psychiatry 61:4-8. 2000..Unfortunately, the ideal antidepressant is yet to be formulated. Pharmacologic characteristics for desirable improvements are discussed relative to the currently available drugs...
Clinical pharmacokinetics of quetiapine: an atypical antipsychoticC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
Clin Pharmacokinet 40:509-22. 2001..Subsequent clinical studies of the plasma concentration versus effect relationships for quetiapine may help to further define guidelines for dosage regimen design...
Substance P: a new era, a new roleC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, USA
Pharmacotherapy 21:1061-9. 2001....
Single-dose pharmacokinetics of methylphenidate in CYP2D6 extensive and poor metabolizersC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
J Clin Psychopharmacol 20:347-9. 2000..These data suggest a lack of involvement of CYP2D6 in the metabolism of MPH. Drugs that are inhibitors of CYP2D6 when taken concurrently with MPH should not affect its plasma concentration...
Pharmacology of antidepressants: focus on nefazodoneC Lindsay Devane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
J Clin Psychiatry 63:10-7. 2002..Relevant pharmacologic and pharmacodynamic effects are summarized that support nefazodone as an attractive choice for both the short- and long-term treatment of depression...
Disposition of morphine in tissues of the pregnant rat and foetus following single and continuous intraperitoneal administration to the motherC L DeVane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
J Pharm Pharmacol 51:1283-7. 1999..These results document why the rat foetus is particularly susceptible to the pharmacodynamic effects of morphine following maternal administration...
Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoproteinHao Jie Zhu
Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, USA
Eur J Pharmacol 578:148-58. 2008..Furthermore, P-glycoprotein may play a minor role in the transport of d-methylphenidate, d-modafinil, and l-modafinil...
Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteersJohn S Markowitz
Medical University of South Carolina, Institute of Psychiatry, RM 246 North, Laboratory of Drug Disposition and Pharmacogenetics, 67 President St, Charleston, SC 29425, USA
Clin Pharmacol Ther 74:536-42. 2003..These conclusions must be weighed in the context of the study's limited assessments and regarded as only the initial investigation into the drug interaction potential of saw palmetto...
Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteersJennifer L Donovan
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425, USA
Drug Metab Dispos 32:906-8. 2004..3 +/- 1.8 microM 2 h after DGT treatment. Our results indicate that DGT is unlikely to alter the disposition of medications primarily dependent on the CYP2D6 or CYP3A4 pathways of metabolism...
Effects of St John's wort (Hypericum perforatum L.) extract on plasma androgen concentrations in healthy men and women: a pilot studyJennifer L Donovan
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, North Charleston, SC 29425, USA
Phytother Res 19:901-6. 2005....
Risperidone and paliperidone inhibit p-glycoprotein activity in vitroHao Jie Zhu
Laboratory of Drug Disposition and Pharmacogenetics, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC, USA
Neuropsychopharmacology 32:757-64. 2007..In particular, RSP may interact with its own active metabolite PALI by promoting its brain concentration through inhibiting P-gp-mediated efflux of PALI across endothelial cells of the BBB...
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoproteinJun Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Psychopharmacology (Berl) 187:415-23. 2006..The multidrug resistance transporter, P-glycoprotein (P-gp), is involved in efflux transport of several antipsychotics in the blood-brain barrier (BBB)...
Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzymeJohn S Markowitz
Department of Pharmaceutical Sciences, Medical University of South Carolina, Institute of Psychiatry, Charleston 29425, USA
JAMA 290:1500-4. 2003..St John's wort is a popular herbal product used to treat depression but it has been implicated in drug interactions...
Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteersJennifer L Donovan
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Drug Metab Dispos 32:1333-6. 2004....
Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basisHao Jie Zhu
Department of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Am J Hum Genet 82:1241-8. 2008..Asp260fs, respectively, compared to the wild-type enzyme. These findings indicate that specific CES1 gene variants can lead to clinically significant alterations in pharmacokinetics and drug response of carboxylesterase 1 substrates...
Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 miceJun-Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA
Psychopharmacology (Berl) 183:490-9. 2006..The mechanisms and consequences of these interactions require further study in humans to establish clinical relevance...
Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteersJohn S Markowitz
Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, USA
J Clin Pharmacol 46:164-71. 2006..The homozygous TT genotype for P-gp resulted in an increased AUC of OLZ for SOT administration but not for either condition where sublingual absorption could occur...
The role of the polymorphic efflux transporter P-glycoprotein on the brain accumulation of d-methylphenidate and d-amphetamineHao-jie Zhu
Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Drug Metab Dispos 34:1116-21. 2006..In addition, d-MPH is a relatively weak P-gp substrate, and its entry into the brain may be limited by P-gp. Furthermore, the mechanism by which d-MPH-induced locomotor activity was attenuated in P-gp KO mice remains to be elucidated...
The effects of probenecid on the disposition of risperidone and olanzapine in healthy volunteersJohn S Markowitz
Department of Pharmaceutical Sciences, Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, Charleston, SC 29425, USA
Clin Pharmacol Ther 71:30-8. 2002..We hypothesized that olanzapine disposition would be altered as a result of decreased glucuronidation, whereas risperidone disposition would be relatively unaffected...
Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteersJohn S Markowitz
Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, Charleston, SC 29425, USA
Clin Pharmacol Ther 74:170-7. 2003..7 +/- 4.4 h versus 14.5 +/- 4.3 h). Our results indicate that garlic extracts are unlikely to alter the disposition of coadministered medications primarily dependent on the CYP2D6 or CYP3A4 pathway of metabolism...
Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunitiesC Lindsay Devane
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA
J Psychopharmacol 20:54-9. 2006....
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomesD Jeffrey Newport
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Am J Psychiatry 164:1214-20. 2007..The objectives of the current study were to quantify placental permeability to antipsychotic medications and to document obstetrical outcomes for women taking these agents proximate to delivery...
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout miceJun-Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA
Psychopharmacology (Berl) 173:132-8. 2004..The interindividual variation in expression of P-gp in BBB may represent a source of variation for the access and effects of methadone in the brain...
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteersJennifer L Donovan
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina (MUSC, Charleston, South Carolina, USA
Clin Pharmacokinet 44:753-65. 2005..In contrast, long-term administration of modafinil significantly decreased systemic exposure to cocaine during the first 180 minutes following intravenous cocaine administration...
Antidepressants in amniotic fluid: another route of fetal exposureAda M Loughhead
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA
Am J Psychiatry 163:145-7. 2006..Although the significance of amniotic fluid exposure remains to be determined, these results demonstrate that maternally administered antidepressants are accessible to the fetus in a manner not previously appreciated...
The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patientJun Sheng Wang
Department of Psychiatry and Behavioral Sciences, and Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, Charleston, SC 29425, USA
Drug Metab Rev 39:723-46. 2007..This review summarizes the current data on drug transporters in the placental passage of medications, with a focus on medications used in clinical psychopharmacology...
Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F(2 alpha), a biomarker for in-vivo lipid peroxidationJennifer L Donovan
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
J Pharm Pharmacol 57:1365-9. 2005..There were no significant differences in the excretion of urinary 8-epi-PGF(2 alpha) after treatment with green tea. We conclude that 14 days of green tea supplementation did not significantly alter in-vivo lipid peroxidation...
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoproteinJun-Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
Int J Neuropsychopharmacol 7:415-9. 2004..These results indicate that P-gp in the blood-brain barrier significantly influences the brain concentrations of risperidone and 9-OH-risperidone by limiting their CNS access...
A novel HPLC fluorescence method for the quantification of methylphenidate in human plasmaHao Jie Zhu
Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, USA
J Chromatogr B Analyt Technol Biomed Life Sci 858:91-5. 2007..This method is the first HPLC assay with non-MS detection providing sufficient reliability and sensitivity for both pre-clinical and clinical studies of MPH...
Antipsychotic drugs inhibit the function of breast cancer resistance proteinJun Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA
Basic Clin Pharmacol Toxicol 103:336-41. 2008..The present results suggest that a potential source of pharmacokinetic interactions exists between BCRP substrates and several antipsychotics...
Aripiprazole brain concentration is altered in P-glycoprotein deficient miceJun Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Schizophr Res 110:90-4. 2009..Thus, factors influencing P-gp activity within the blood brain barrier in humans may have implications for the therapeutic effects and tolerability of aripiprazole...
Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatizationHao Jie Zhu
Laboratory of Drug Disposition and Pharmacogenetics, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
J Chromatogr B Analyt Technol Biomed Life Sci 846:351-4. 2007..3 ng/mL. The relative standard deviations of intra-day and inter-day variations were < or =8.30% and 7.47%, respectively. This method is rapid, sensitive, and suitable for both basic and clinical studies of atomoxetine...
Modafinil and cocaine interactionsRobert Malcolm
Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Am J Drug Alcohol Abuse 32:577-87. 2006..Modafinil significantly dampened scores on Visual Analog Scale measures as compared to baseline cocaine conditions. No significant alterations in labs occurred. Further outpatient trials of modafinil appear to be warranted...
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteersHeidi L Liston
Department of Psychiatry, Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, Charleston, South Carolina 29425, USA
J Clin Psychopharmacol 22:169-73. 2002..These data define the time course of a persistent effect that fluoxetine, sertraline, and paroxetine have on CYP2D6 following drug discontinuation and should be considered when initiating therapy with a CYP2D6 substrate...
Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adultsJohn S Markowitz
Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425 0742, USA
Clin Pharmacokinet 42:393-401. 2003..To compare the rate and extent of absorption of DL-threo-methylphenidate (MPH) from two modified-release MPH formulations at their respective recommended starting doses in healthy adult volunteers...
Characterization of P-glycoprotein inhibition by major cannabinoids from marijuanaHao-jie Zhu
Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, Charleston, SC 29425, USA
J Pharmacol Exp Ther 317:850-7. 2006..These findings indicate that CBD significantly inhibits P-gp-mediated drug transport, suggesting CBD could potentially influence the absorption and disposition of other coadministered compounds that are P-gp substrates...
In vitro P-glycoprotein affinity for atypical and conventional antipsychoticsDavid W Boulton
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, PO Box 250861, Charleston, SC 29425, USA
Life Sci 71:163-9. 2002..These results suggest that P-gp is likely to influence the access to the brain of all of the atypical antipsychotics studied to various degrees. In vivo studies are needed to confirm these findings...
Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteersJennifer L Donovan
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Drug Metab Dispos 31:519-22. 2003....
A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory studyJohn S Markowitz
Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
J Child Adolesc Psychopharmacol 16:687-98. 2006..However, the present exploratory studies reflect receptor binding affinities only. The specific pharmacological activities (i.e., agonism vs. antagonism) of these compounds await further exploration...
Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotypingNatalie L LeVasseur
Department of Chemistry and Biochemistry, College of Charleston, Charleston, SC, USA
J Chromatogr B Analyt Technol Biomed Life Sci 862:140-9. 2008..Clinical implications concerning rational drug selection for an identified or suspected MPH PM are discussed...
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitroJun Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Institute of Psychiatry, Medical University of South Carolina, 67 President St, Suite 246 North, Charleston, SC 29425, USA
Drug Metab Dispos 31:742-7. 2003..These data suggest that coadministration of inhibitors of CYP3A4 and CYP2C8 may produce clinically significant drug-drug interactions with methadone...
Effect of Ginkgo biloba extract on plasma steroid concentrations in healthy volunteers: a pilot studyJohn S Markowitz
Department of Pharmaceutical Sciences, Medical University of South Carolina, Children s Research Institute, Charleston, South Carolina 29425, USA
Pharmacotherapy 25:1337-40. 2005..To determine if a standardized ginkgo supplement significantly alters concentrations of circulating androgenic steroids in humans...
Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studiesJennifer L Donovan
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Ther Drug Monit 25:197-202. 2003..The validation data support the use of this method for human pharmacokinetic studies of modafinil in patients with known or suspected use of common antidepressants, psychostimulants, and drugs of abuse...
Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivoJennifer L Donovan
Laboratory of Drug Disposition and Pharmacogenetics, Medical University of South Carolina, 67 President St. suite 246 N, Charleston, SC 29425, USA
Food Chem Toxicol 41:1199-201. 2003..05). We conclude that quinine as consumed in tonic water does not inhibit CYP2D6 activity in vivo. Thus, quinine should not alter the metabolism of CYP2D6 substrates taken concomitantly with tonic water...
P-glycoprotein does not actively transport nicotine and cotinineJun-Sheng Wang
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina 49425, USA
Addict Biol 10:127-9. 2005..The observed carrier-mediated nicotine transport in various cell lines may be mediated by other transporter proteins but not P-gp...
Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depressionC Lindsay Devane
Department of Psychiatry, Medical University of South Carolina, 67 President Street, P O Box 250861, Room PH246, Charleston, SC 29425, USA
Am J Manag Care 11:S344-53. 2005....
P-glycoprotein inhibition potentiates the behavioural and neurochemical actions of risperidone in ratsAlejandra M Pacchioni
Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA
Int J Neuropsychopharmacol 13:1067-77. 2010..These results provide functional evidence concordant with prior data for increased brain levels of risperidone following PSC 833 treatment...
Pharmacokinetics, drug interactions, and tolerability of paroxetine and paroxetine CRC Lindsay Devane
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
Psychopharmacol Bull 37:29-41. 2003..Paroxetine controlled-release is an enteric-coated formulation with release features that may enhance clinical outcome by modifying absorption-related pharmacokinetics, improving tolerability, and maintaining therapeutic benefits..
Hypotension and bradycardia in a healthy volunteer following a single 5 mg dose of olanzapineJohn S Markowitz
Institute of Psychiatry, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston 29425, USA
J Clin Pharmacol 42:104-6. 2002..This case suggests that atypical antipsychotics, although generally better tolerated than conventional agents, may still result in untoward reactions that may be partially due to individual differences in drug absorption and metabolism...
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorderS Craig Risch
Department of Psychiatry, University of California, San Francisco, CA 94143 0984, USA
Int J Neuropsychopharmacol 9:603-5. 2006..Thus, in this study, donepezil did not induce or worsen depressive symptoms in schizophrenic and schizoaffective disorder patients...
Pro-inflammatory biomakers in depression: treatment with venlafaxineJohn E Piletz
Department of Psychiatry, Loyola University Chicago, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL 60153, USA
World J Biol Psychiatry 10:313-23. 2009..09), and MCP-1 (P=0.02), suggesting that these biomarkers may have become selectively lowered in the serotonergic dose range of venlafaxine. This is the first report of venlafaxine's possible effect on pro-inflammatory biomarkers...
Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorderHelen R Winter
AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
Hum Psychopharmacol 22:469-76. 2007..To determine whether there is a pharmacokinetic drug interaction between quetiapine fumarate and divalproex sodium...
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot studyS Craig Risch
Langley Porter Psychiatric Institute, University of California San Francisco 94143 0984, USA
Schizophr Res 93:131-5. 2007..018, n=13). These results are discussed with respect to other studies using cholinesterase inhibitors as an augmentation strategy in schizophrenia...
Research Grants
- Pharmacogenetics of MethadoneC Devane; Fiscal Year: 2003..This study will form the basis for subsequent studies which should provide a more rational basis for dosing of methadone in pregnant addicts. ..
- PGP Regulation of Antipsychotic Exposure and EffectsC Devane; Fiscal Year: 2007..The results of this research will provide support for translational studies in humans to refine treatment guidelines for the use of this class of medications in severely mentally ill patients. ..
- Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)C LINDSAY LINDSAY DEVANE; Fiscal Year: 2010..PROJECT NARRATIVE: Autism occurs in approximately 1 in 150 children. The investigators propose a multi-center clinical trial to provide evidence-based guidance in the selection and monitoring of durg treatment of autism. ..
